Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)
NCT00406172 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2024-06-05
Summary
To report safety and efficacy of intravitreal injection of bevacizumab in patients with cystoid macular edema secondary to cataract surgery.
Conditions
- Cystoid Macular Edema
Interventions
- DRUG
Sponsors & Collaborators
-
Asociación para Evitar la Ceguera en México
lead OTHER
Principal Investigators
-
Victoria Cubas-Lorenzo, MD · APEC México
Study Design
- Allocation
- NON_RANDOMIZED
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-11-30
- Primary Completion
- 2006-11-30
- Completion
- 2006-11-30
Countries
- Mexico
More Related Trials
-
Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema
NCT03211741 ·Status: RECRUITING ·Phase: PHASE4
-
Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular Degeneration
NCT00556348 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Bevacizumab (Avastin) on Pterygium
NCT00592176 ·Status: COMPLETED ·Phase: PHASE2
-
Bevacizumab and Retinal Vascular Occlusions
NCT00347711 ·Status: WITHDRAWN ·Phase: PHASE3
-
Intravitreal Bevacizumab for Age-Related Macular Degeneration
NCT00347165 ·Status: TERMINATED ·Phase: PHASE2
-
Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema
NCT00417716 ·Status: WITHDRAWN ·Phase: PHASE3
-
Intravitreal Bevacizumab for Inflammatory Neovascular Membranes
NCT00407121 ·Status: WITHDRAWN ·Phase: PHASE3
-
Eye Injections of Bevacizumab for Lowering Risk of Scar Tissue in the Retina and Repeated Retinal Detachment.
NCT01860586 ·Status: COMPLETED ·Phase: NA
-
Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD)
NCT00407719 ·Status: COMPLETED ·Phase: PHASE1
-
To Compare Therapeutic Effect of Intravitreal Bevacizumab and Triamcinolone in Resistant Uveitic Cystoid Macular Edema
NCT00371111 ·Status: UNKNOWN ·Phase: PHASE1
-
Effect of Avastin in Juxtafoveal Telangiectasias
NCT00406380 ·Status: WITHDRAWN ·Phase: PHASE3
-
Efficacy, Safety and Tolerability of Repeated Dosis of Intravitreous Bevacizumab in Uveitic Macular Oedema
NCT01095809 ·Status: TERMINATED ·Phase: PHASE3
-
Systemic Avastin Therapy in Age-Related Macular Degeneration
NCT00531024 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical Trial
NCT00370851 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Bevacizumab (Avastin) in Treatment of Acute NMO Exacerbations
NCT01777412 ·Status: COMPLETED ·Phase: PHASE1
-
Bevacizumab for Central Retinal Vein Occlusion Study
NCT00906685 ·Status: COMPLETED ·Phase: PHASE3
-
Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema
NCT01298076 ·Status: COMPLETED ·Phase: PHASE2
-
Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
NCT00423059 ·Status: COMPLETED ·Phase: NA
-
Multifocal Electrophysiologic Findings After Intravitreal Bevacizumab(Avastin)Treatment
NCT00417833 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD
NCT01256580 ·Status: WITHDRAWN ·Phase: NA
-
Subconjunctival Bevacizumab to Prevent Bleb Failure After Glaucoma Filtration Surgery
NCT00468429 ·Status: UNKNOWN ·Phase: PHASE4
-
Avastin for PDR (Proliferative Diabetic Retinopathy)
NCT01270542 ·Status: COMPLETED ·Phase: NA
-
Central Retinal Vein Occlusion (CRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only.
NCT04601701 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Changes of Inflammatory Proteins in Aqueous Humour of Subjects Treated With Avastin vs Lucentis
NCT01760746 ·Status: COMPLETED
-
Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration
NCT00347399 ·Status: TERMINATED ·Phase: PHASE2